Actively Recruiting
FMT in Initial CDI
Led by Turku University Hospital · Updated on 2025-04-11
140
Participants Needed
1
Research Sites
343 weeks
Total Duration
On this page
Sponsors
T
Turku University Hospital
Lead Sponsor
S
Satakunta Central Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The study explores fecal microbiota transfer via retention enema after the first clostridioides difficile episode.
CONDITIONS
Official Title
FMT in Initial CDI
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age greater than 18 years
- Positive PCR test for C. difficile in feces with clinical symptoms of enteritis
- Complete resolution of diarrhea during antibiotic treatment for C. difficile
- No other antibacterial treatments ongoing
- No current use of probiotics
- Signed informed consent form
You will not qualify if you...
- Pregnant women
- Ongoing need for antibacterial treatment
- Life expectancy less than 1 year
- Previous C. difficile infection within the last 3 months
- Unable to provide written consent, such as due to dementia
- Fecal incontinence or inability to retain enema
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Turku University hospital
Turku, Finland
Actively Recruiting
Research Team
T
Teppo U Stenholm
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here